There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Looking Ahead The FDA’s full-scale adoption of AI technology represents a leap forward in regulatory oversight. By ...

Discover how AI is transforming healthcare with insights from Microsoft leaders on AI advancements, success stories, and ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement generative artificial intelligence ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

Quantum computing has the potential to significantly transform artificial intelligence due to its exponentially faster ...